RxDoctor Payments Data

Jesse Basadre, MD

Surgery of the Hand · Miami, FLNPI 1609941244

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 47 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 13 manufacturers reported payments, led by Axogen at 24.8% of the total. Reporting peaked in 2023 at $839 and has fallen 53.1% since, to $393 in 2025. That places this record below the midpoint for surgery of the hand clinicians in FL, where the typical reported total is $3,069.

$2,184in general payments, 2019–2025

Across 47 payments — averaging $46.47 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Axogen$541
  • Integra Lifesciences Corporation$526
  • Stryker$425
  • Polynovo North America LLC$175
  • Medline Industries LP$124
  • Endo Pharmaceuticals Inc.$110
  • plus $283 from 7 others

What the payments were for

  • Food & beverage$2,184100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,184 in reported general payments places this provider in the 35th percentile of 60 surgery of the hand providers in Florida.

See all surgery of the hand providers in Florida

Medicare billing

Part B allowed, 2024
$40,422
Medicare patients
39
Services billed
224

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Cephalexin198$762
Tramadol Hcl232$268
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim37$169

Paid to pharmacies, not to this prescriber.

Other surgery of the hand in Miami

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →